Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Montserrat Rafel"'
Autor:
Maria Julia, Montoro, Helena, Pomares, Rosa, Coll, Teresa, Bernal Del Castillo, Mar, Tormo, Ana, Jiménez, Salut, Brunet, Javier, Casaño, Itziar, Oiartzabal, María, Díez-Campelo, Fernando, Ramos, Rafael, Romero, Eduardo, Salido-Fiérrez, Carmen, Pedro, Joan, Bargay, Carolina, Muñoz-Novas, Rocío, López, Montserrat, Rafel, David, Valcárcel
Publikováno v:
Scientia
Clinical practice; Myelodysplastic syndrome; Treatment Pràctica clínica; Síndrome mielodisplàstica; Tractament Práctica clínica; Síndrome mielodisplásico; Tratamiento Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases witho
Autor:
Laura Rosiñol, Jordi Esteve, Montserrat Tuset, Emili Montserrat, Benet Nomdedeu, María Perales, Silvia Montoto, Luis Villela, Montserrat Rafel, Francesc Cobo, Joan Bladé
Publikováno v:
British Journal of Haematology. 113:422-424
Thalidomide is active in patients with refractory myeloma. Seventeen patients (nine men/eight women, median age 73 years) with multiple myeloma (MM) were treated with thalidomide. Fifteen patients had refractory disease and two untested relapse. The
Publikováno v:
Acta Dermato-Venereologica. 78:198-200
Mature T-cell malignancies of extracutaneous origin are rare disorders. T-cell prolymphocytic leukaemia (T-PLL) is the most common form of all mature T-cell leukaemias in adults. Secondary skill involvement by T-PLL has been reported in 25% of patien
Autor:
Francisco Zuazu, José María Beltrán, Luis Hernández Nieto, Francisco Cervantes, Emilio Montserrat, Consuelo Rayón, Montserrat Rafel, Juan García Talavera
Publikováno v:
Cancer. 88(2)
BACKGROUND Deoxycoformycin (DCF) has been reported to produce high response rates in patients with hairy cell leukemia (HCL), but to the authors' knowledge data regarding experience with such therapy in a large HCL series are scarce. METHODS Between
Autor:
Montserrat Rafel, Arturo Pereira, Francesc Cobo, Francisco Cervantes, Ciril Rozman, Jordi Esteve, Emilio Montserrat
Publikováno v:
British journal of haematology. 97(3)
To contribute to a better knowledge of the prognosis of idiopathic myelofibrosis (IM), the prognostic value of the presenting features in 106 patients diagnosed with IM at a single institution during a 21-year period was retrospectively analysed. Med